[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  BioCentury [@BioCentury](/creator/twitter/BioCentury) on x 16.3K followers Created: 2025-07-18 21:30:12 UTC Capital flows continue in Asia. Ascentage Pharma raises $192M in Hong Kong placement while Korea-based Illimis raises $XX million in a series B round: BioCentury's latest Finance Report  XXX engagements  **Related Topics** [finance](/topic/finance) [seed funding](/topic/seed-funding) [kong](/topic/kong) [hong kong](/topic/hong-kong) [$192m](/topic/$192m) [Post Link](https://x.com/BioCentury/status/1946321633376944468)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
BioCentury @BioCentury on x 16.3K followers
Created: 2025-07-18 21:30:12 UTC
Capital flows continue in Asia. Ascentage Pharma raises $192M in Hong Kong placement while Korea-based Illimis raises $XX million in a series B round: BioCentury's latest Finance Report
XXX engagements
Related Topics finance seed funding kong hong kong $192m
/post/tweet::1946321633376944468